492 related articles for article (PubMed ID: 16596424)
21. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
[TBL] [Abstract][Full Text] [Related]
22. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
23. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
24. Expression of tissue factor correlates with grade of malignancy in human glioma.
Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
[TBL] [Abstract][Full Text] [Related]
27. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
29. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
30. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Bresalier RS; Yan PS; Byrd JC; Lotan R; Raz A
Cancer; 1997 Aug; 80(4):776-87. PubMed ID: 9264362
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
32. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
[TBL] [Abstract][Full Text] [Related]
33. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
[TBL] [Abstract][Full Text] [Related]
35. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
36. Biological role of thymidine phosphorylase in human astrocytic tumors.
Tanioka K; Takeshima H; Hirano H; Kimura T; Nagata S; Akiyama S; Kuratsu J
Oncol Rep; 2001; 8(3):491-6. PubMed ID: 11295068
[TBL] [Abstract][Full Text] [Related]
37. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
38. The glucose transporter and blood-brain barrier of human brain tumors.
Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
[TBL] [Abstract][Full Text] [Related]
39. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]